Not all individuals with CLL demand therapy. Even with all current improvements, the iwCLL continue to endorses watchful observation for individuals with asymptomatic disorder.86 This recommendation is predicated on at the least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituxim